original ) (raw )HIV-1 fusion protein exerts complex immunosuppressive effects
Omri Faingold
Trends in Biochemical Sciences, 2013
View PDFchevron_right
Effect of E1(64–81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models
Ma Antònia Busquets
Biochimica et Biophysica Acta (BBA) - Biomembranes, 2011
View PDFchevron_right
HIV-1 Replication Is Inhibited by a Pseudo-substrate Peptide That Blocks Tat Transactivation
Takashi Okamoto
Virology, 2000
View PDFchevron_right
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
Mark Connors
Science, 2016
View PDFchevron_right
An Immunomodulating Motif of the HIV-1 Fusion Protein Is Chirality-independent: IMPLICATIONS FOR ITS MODE OF ACTION
Omri Faingold , Nathali Kaushansky
Journal of Biological Chemistry, 2013
View PDFchevron_right
Fusion Peptides Derived from the HIV Type 1 Glycoprotein 41 Associate within Phospholipid Membranes and Inhibit Cell-Cell Fusion. STRUCTURE-FUNCTION STUDY
Yossef Kliger
Journal of Biological Chemistry, 1997
View PDFchevron_right
Interaction between HIV1 Rev and Integrase Proteins: A BASIS FOR THE DEVELOPMENT OF ANTI-HIV PEPTIDES
Abraham Loyter
Journal of Biological Chemistry, 2007
View PDFchevron_right
An extended CCR5-ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions
Fred Naider
FEBS Journal, 2015
View PDFchevron_right
Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides
yolanda perez
Scientific Reports, 2019
View PDFchevron_right
Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques
Nicola Borthwick
European Journal of Immunology, 2010
View PDFchevron_right
Solution structure of peptides from HIV-1 Vpr protein that cause membrane permeabilization and growth arrest
Ian Macreadie
Journal of Peptide Science, 1998
View PDFchevron_right
Anti-HIV Activity of Multibranched Peptide Constructs Derived either from the Cleavage Sequence or from the Transmembrane Domain (gp41) of the Human Immunodeficiency Virus Type 1 Envelope
kamel mabrouk
Virology, 1996
View PDFchevron_right
An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity
Pedro Borrego
AIDS, 2013
View PDFchevron_right
HIV-1 Membrane Fusion Mechanism: Structural Studies of the Interactions between Biologically-Active Peptides from gp41
Kelly Guthrie
Biochemistry, 1996
View PDFchevron_right
A Cell-penetrating Helical Peptide as a Potential HIV-1 Inhibitor
Xiaohe Tong
Journal of Molecular Biology, 2008
View PDFchevron_right
TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function
Estelle Oberlin
Current Biology, 1997
View PDFchevron_right
Structural Analysis and Assembly of the HIV-1 Gp41 Amino-Terminal Fusion Peptide and the Pretransmembrane Amphipathic-At-Interface Sequence †
David Andreu
Biochemistry, 2006
View PDFchevron_right
Peptides Trap the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Fusion Intermediate at Two Sites
nga nguyen
Journal of Virology, 2003
View PDFchevron_right
HIV Fusion Peptide Penetrates, Disorders and Softens T-Cell Membrane Mimics
Stephanie Tristram-nagle , Edgar Kooijman
Biophysical Journal, 2011
View PDFchevron_right
Determinants of Membrane Activity from Mutational Analysis of the HIV Fusion Peptide
Oscar Torres
Biochemistry, 2011
View PDFchevron_right
Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages
kamel mabrouk
Peptides 1994, 1995
View PDFchevron_right
A Rationally Engineered Anti-HIV Peptide Fusion Inhibitor with Greatly Reduced Immunogenicity
Heinfried Radeke
Antimicrobial Agents and Chemotherapy, 2013
View PDFchevron_right
Conformation of the HIV-1 Gag Protein in Solution
Siddhartha Datta
Journal of Molecular Biology, 2007
View PDFchevron_right
Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide
Sonu Kumar
Nature Communications, 2019
View PDFchevron_right
The Polar Region Consecutive to the HIV Fusion Peptide Participates in Membrane Fusion †
Richard Epand
Biochemistry, 2000
View PDFchevron_right
Structural Constraints Imposed by the Conserved Fusion Peptide on the HIV-1 gp41 Epitope Recognized by the Broadly Neutralizing Antibody 2F5 †
Emil Pai
The Journal of Physical Chemistry B, 2009
View PDFchevron_right
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
Mark Muldoon
Virology, 2007
View PDFchevron_right
Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
Nicola Borthwick
Molecular Therapy, 2014
View PDFchevron_right
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
Gengcheng Yang
Scientific Reports
View PDFchevron_right
HIV-1 Fusion Peptide Decreases Bending Energy and Promotes Curved Fusion Intermediates
Stephanie Tristram-nagle
Biophysical Journal, 2007
View PDFchevron_right
HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
Iole Macchia
PLoS ONE, 2012
View PDFchevron_right
Tryptophan regulated expression and aqueous two-phase separation of recombinant HIV-fusion peptides
Scott Winston
Enzyme and Microbial Technology, 1997
View PDFchevron_right
A Compensatory Mutation Provides Resistance to Disparate HIV Fusion Inhibitor Peptides and Enhances Membrane Fusion
Preston Marx
PLoS ONE, 2013
View PDFchevron_right